newsfilter
← Latest News
GlobeNewswire·

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating ADMA Biologics, Inc. (NASDAQ:ADMA) for potential securities law violations. Investors who have lost money in their ADMA Biologics, Inc.